Oxeltis was founded in 2010 by former researchers from Idenix Pharmaceuticals in Montpellier, France. Born from deep pharmaceutical expertise, the company was built on a single conviction: that sound and robust organic chemistry, rigorously executed, is the cornerstone of successful drug discovery.
Montpellier
CAP GAMMA 1682 rue de la Valsière BP 7247 34086 Montpellier – Cedex 4
Need a specialist partner for nucleoside or phosphoramidites building block synthesis?
From a non-commercially modified phosphoramidite building block for oligonucleotide project to a complex lead optimization program of highly modified nucleoside for antiviral — tell us about your project and we'll come back to you within 48 hours.
